New Target is Single digit $6 at today's pps.
are you looking for a shortcut to make quick profit without putting any effort ... that might byte back now or later ...
Compared to biotech research companies with only one risky product in the pipeline like ARNA, EXAS, VVUS this should be priced above $30 even with latest FDA rejection ...
But you should do your own analysis, before investing your money and enjoy whatever the outcome ...
I've owned this stock off and on since 2000. Recently only for covered call options. I'm just trying to get a feel for direction. Hopefully, someone may have some useful information that I might not.
Thank you for your reply. good luck to all of us.
Piperjay says it is $20 within 12 months from Tuesday downgrade.
I think they're the lowest.
Most bullish Webbush seems to think it is $45 but they don't give timeline.
Currently around $20 plus.